Navigation Links
Greenberg Traurig Shareholder Jennifer A. Camacho Selected to Receive Mass High Tech's 2011 All-Stars Award
Date:9/9/2011

BOSTON, Sept. 9, 2011 /PRNewswire/ -- Mass High Tech has selected Greenberg Traurig shareholder Jennifer A. Camacho to be a recipient of its 2011 All-Stars Award, one that recognizes 15 driven and influential leaders of New England's innovation economy.  

Camacho will be recognized for her wide range of experience in and contribution to the life sciences sector.  As a patent attorney, she represents pharmaceutical and biotechnology clients. Camacho brings a real-world perspective to client representation from her tenure as chief patent counsel, vice president of intellectual property and general counsel at a venture-backed start-up company in the emerging field of synthetic biology and DNA synthesis.  She is a founding team member for the International Consortium for Polynucleotide Synthesis, Inc., and currently serves on the board of directors for the Center for Policy on Emerging Technologies in Washington, D.C.  In addition,  Camacho serves as a judge and mentor for the MassChallenge, Inc. annual startup competition and accelerator program.

"The 2011 All-Stars have a proven record in leading not only their own companies but in helping their industry thrive and in guiding entrepreneurs who are building the successful tech companies of tomorrow," said Mass High Tech publisher Doug Banks.  "The companies and industries that they have helped to build are the basis of the economic engine that provides jobs and spawns innovation throughout New England and the United States."

Honorees will be profiled in a special report on MassHighTech.com and recognized at an evening awards celebration and networking reception on Wednesday, November 16th, at the House of Blues in Boston.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, full-service law firm with approximately 1,800 attorneys serving clients from more than 30 offices in the United States, Europe and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal's 2011 NLJ 250. In the U.K., the firm operates as Greenberg Traurig Maher LLP. Greenberg Traurig has a strategic alliance with the independent law firm, Studio Santa Maria in Milan and Rome. The firm was Chambers and Partners' USA Law Firm of the Year in 2007 and among the Top 3 in the International Law Firm of the Year at the 2009 The Lawyer Awards. For additional information, please visit www.gtlaw.com.


'/>"/>
SOURCE Greenberg Traurig, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
3. Mymetics Corporation Important Shareholders Information Conference Call
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
6. Chromos announces shareholder approval of Arrangement
7. Sangui Bio Tech International Inc. Shareholders Meeting Delayed to Include FY 2008 Report
8. ARIUS sale approved by shareholders
9. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
10. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
11. Insmed to Seek Shareholder Approval for Reverse Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, Inc. ... on developing aerosolized KL4 surfactant therapies for respiratory ... has approved an inducement award as a component ... its newly appointed President and Chief Executive Officer.  ... Committee on February 1, 2016 and granted as ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 Harvard ... a biotechnology company developing bioengineered organ implants for ... today announced that CEO Jim McGorry , ... Investor Conference on Tuesday, February 9, 2016 ... York City . HART,s presentation will be ...
(Date:2/3/2016)... ON (PRWEB) , ... February 03, 2016 , ... ... and validating a series of potential targets (epitopes) specific to misfolded, propagating strains ... targets to create specific monoclonal antibody therapeutics for Alzheimer’s. , Following on from ...
(Date:2/3/2016)... Mass. , Feb. 3, 2016  Silk Therapeutics, Inc., ... financing round. Silk Therapeutics has now raised a total of ... made by the company. The Series A2 round was led ... Massachusetts , with participation from new investors Lear Corporation ... Sheri and Roy P. Disney ; Richard Sackler , ...
Breaking Biology Technology:
(Date:1/7/2016)... LONDON , Jan. 7, 2016 ... demand for biopharmaceutical products such as biologics and ... pressure to reduce healthcare expenditure, growing demand for ... growing aging population. Biosimilars are similar versions of ... with regards to their quality, safety, and efficacy. ...
(Date:1/6/2016)... 6, 2016  Varam Capital, a provider of micro-finance ... to deliver advanced authentication solutions to their clients. Varam ... poor. A loan of a few thousand rupees may ... the ability to purchase livestock or equipment for a ... stock for a local store. ...
(Date:1/6/2016)... 6, 2016   A&D Medical , a global ... services, will be unveiling a new line of personal ... – LifeSource UltraConnect – at CES 2016, with the introduction ... blood pressure monitors. ... wrist and upper arm wireless blood pressure monitors represent ...
Breaking Biology News(10 mins):